This market resolves to Yes if a clinical trial aimed at modulating the STING pathway as a treatment for Alzheimer's disease is officially registered on a clinical trial database or publicly announced by July 31, 2026. Evidence must be available on platforms such as ClinicalTrials.gov or equivalent.